Actavis (Now Allergan)

Actavis (Now Allergan) company information, Employees & Contact Information

Explore related pages

Actavis (Now Allergan) email format Actavis (Now Allergan) management contacts

Related company profiles:

We would like to invite you to follow our new Allergan page at https://www.linkedin.com/company/allergan?trk=top_nav_home

Company Details

Employees
1.35K
Founded
-
Address
1 Grand Canal Square, Docklands,united States
Phone
1(800) 900-1644
Email
te****@****arm.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
actavis.com
Keywords
Generic Pharmaceuticals, Branded Pharmaceuticals, Over-the-Counter Pharmaceuticals, Biologics.
HQ
Dublin
Competitors
Allergan Aesthetics, an AbbVie Company, Galderma, Actavis plc (now Allergan), Allergan, AbbVie, Teva Pharmaceuticals, Sanofi, GSK, Pfizer, SkinMedica®.
Looking for a particular Actavis (Now Allergan) employee's phone or email?

Actavis (Now Allergan) Questions

News

Actavis Completes Acquisition of Auden Mckenzie - PR Newswire

Actavis Completes Acquisition of Auden Mckenzie PR Newswire

Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue - MultiVu

Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue MultiVu

425 - SEC.gov

425 SEC.gov

Actavis And Perrigo Receive FDA Approval Of Guaifenesin/Pseudoephedrine, The Store Brand Equivalent To Mucinex® D Tablets - PR Newswire

Actavis And Perrigo Receive FDA Approval Of Guaifenesin/Pseudoephedrine, The Store Brand Equivalent To Mucinex® D Tablets PR Newswire

Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults - PR Newswire

Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults PR Newswire

Actavis Launches Generic Version of Intuniv® - PR Newswire

Actavis Launches Generic Version of Intuniv® PR Newswire

Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer - PR Newswire

Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer PR Newswire

Actavis Receives Final Approval for Generic Version of Subutex® - PR Newswire

Actavis Receives Final Approval for Generic Version of Subutex® PR Newswire

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition - PR Newswire

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition PR Newswire

Actavis Confirms Generic Quillivant XR® Patent Challenge - PR Newswire

Actavis Confirms Generic Quillivant XR® Patent Challenge PR Newswire

Actavis Receives FDA Approval of SAPHRIS® for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder - PR Newswire

Actavis Receives FDA Approval of SAPHRIS® for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder PR Newswire

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - PR Newswire

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company PR Newswire

Actavis Completes Allergan Acquisition - PR Newswire

Actavis Completes Allergan Acquisition PR Newswire

Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation - PR Newswire

Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation PR Newswire

Actavis Completes Forest Laboratories Acquisition - PR Newswire

Actavis Completes Forest Laboratories Acquisition PR Newswire

Actavis and Medicines360 Announce FDA Approval of LILETTA™ (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years - PR Newswire

Actavis and Medicines360 Announce FDA Approval of LILETTA™ (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years PR Newswire

Actavis' Generic Version of Micardis® Receives FDA Approval - PR Newswire

Actavis' Generic Version of Micardis® Receives FDA Approval PR Newswire

Actavis and Adamas Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride - PR Newswire

Actavis and Adamas Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride PR Newswire

Actavis Receives U.S. FDA Approval for AVYCAZ™ (CEFTAZIDIME-AVIBACTAM) - PR Newswire

Actavis Receives U.S. FDA Approval for AVYCAZ™ (CEFTAZIDIME-AVIBACTAM) PR Newswire

Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries - PR Newswire

Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries PR Newswire

Actavis Launches NAMZARIC™ (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease - PR Newswire

Actavis Launches NAMZARIC™ (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease PR Newswire

Actavis Completes Acquisition of Furiex Pharmaceuticals - PR Newswire

Actavis Completes Acquisition of Furiex Pharmaceuticals PR Newswire

Generic Temovate Launched by Actavis - Medical Professionals Reference

Generic Temovate Launched by Actavis Medical Professionals Reference

Actavis To Present At The Goldman Sachs Conference; Webcast At 12:00 PM ET - RTTNews

Actavis To Present At The Goldman Sachs Conference; Webcast At 12:00 PM ET RTTNews

Actavis Receives FDA Approval for VIIBRYD® (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose - PR Newswire

Actavis Receives FDA Approval for VIIBRYD® (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose PR Newswire

Actavis Extends Exclusive Agreement to Distribute Authorized Generic Concerta® - PR Newswire

Actavis Extends Exclusive Agreement to Distribute Authorized Generic Concerta® PR Newswire

Actavis Completes Warner Chilcott Acquisition - PR Newswire

Actavis Completes Warner Chilcott Acquisition PR Newswire

Actavis To Present At Bank Of America Conference ; Webcast At 11:40 AM ET - RTTNews

Actavis To Present At Bank Of America Conference ; Webcast At 11:40 AM ET RTTNews

Actavis to Acquire Durata Therapeutics, Inc. - PR Newswire

Actavis to Acquire Durata Therapeutics, Inc. PR Newswire

Actavis Launches Generic Lidoderm® - PR Newswire

Actavis Launches Generic Lidoderm® PR Newswire

Actavis Confirms Generic AndroGel® 1.62% Patent Challenge - PR Newswire

Actavis Confirms Generic AndroGel® 1.62% Patent Challenge PR Newswire

Watson Pharmaceuticals, Inc. is Now Actavis, Inc. - PR Newswire

Watson Pharmaceuticals, Inc. is Now Actavis, Inc. PR Newswire

VIBERZI™ (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine - PR Newswire

VIBERZI™ (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine PR Newswire

Actavis Approved for Generic Subutex - Medical Professionals Reference

Actavis Approved for Generic Subutex Medical Professionals Reference

Letter to Stakeholders: Pfizer 2015 Annual Review - Pfizer

Letter to Stakeholders: Pfizer 2015 Annual Review Pfizer

Allergan Issues Voluntary Nationwide Recall in the U.S. of Specific Lots of REFRESH® Lacri-Lube®, REFRESH P.M. ®, FML® (fluorometholone ophthalmic ointment) 0.1%, and Blephamide® (sulfacetamide sodium and prednisolone acetate ophthalmic ointm - PR Newswire

Allergan Issues Voluntary Nationwide Recall in the U.S. of Specific Lots of REFRESH® Lacri-Lube®, REFRESH P.M. ®, FML® (fluorometholone ophthalmic ointment) 0.1%, and Blephamide® (sulfacetamide sodium and prednisolone acetate ophthalmic ointm PR Newswire

Investments and Management Moves - communitynews.org

Investments and Management Moves communitynews.org

Actavis CEO steps down - IceNews - Daily News

Actavis CEO steps down IceNews - Daily News

CMA alleges anti-competitive agreements for hydrocortisone tablets - GOV.UK

CMA alleges anti-competitive agreements for hydrocortisone tablets GOV.UK

Actavis pharmaceuticals unaffected by Iceland crisis - IceNews - Daily News

Actavis pharmaceuticals unaffected by Iceland crisis IceNews - Daily News

Actavis to launch first ever OTC oral antibiotic in UK - PressPort

Actavis to launch first ever OTC oral antibiotic in UK PressPort

Companies like Actavis (Now Allergan)

Galderma logo - Similar company to Actavis (Now Allergan)

Galderma

8.13K
Actavis plc (now Allergan) logo - Similar company to Actavis (Now Allergan)

Actavis Plc (Now All...

NA
AbbVie logo - Similar company to Actavis (Now Allergan)

Abbvie

57.01K
Sanofi logo - Similar company to Actavis (Now Allergan)

Sanofi

88.33K
Teva Pharmaceuticals logo - Similar company to Actavis (Now Allergan)

Teva Pharmaceuticals

29.77K
Allergan logo - Similar company to Actavis (Now Allergan)

Allergan

10.48K
SkinMedica® logo - Similar company to Actavis (Now Allergan)

Skinmedica®

100
Allergan Aesthetics, an AbbVie Company logo - Similar company to Actavis (Now Allergan)

Allergan Aesthetics,...

2.15K
GSK logo - Similar company to Actavis (Now Allergan)

Gsk

90.45K
Pfizer logo - Similar company to Actavis (Now Allergan)

Pfizer

100.69K

Top Actavis (Now Allergan) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant